Free Trial

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$99.24 -2.93 (-2.87%)
Closing price 04:00 PM Eastern
Extended Trading
$99.30 +0.06 (+0.06%)
As of 05:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADUS vs. HIMS, OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, and LFST

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

Addus HomeCare vs.

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Hims & Hers Health currently has a consensus price target of $38.25, indicating a potential upside of 34.16%. Addus HomeCare has a consensus price target of $132.78, indicating a potential upside of 33.14%. Given Hims & Hers Health's higher probable upside, research analysts clearly believe Hims & Hers Health is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.21
Addus HomeCare
1 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
3.00

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 4.6% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 16 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for Hims & Hers Health and 10 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.01 beat Hims & Hers Health's score of 0.77 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
14 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare received 287 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.89% of users gave Addus HomeCare an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
43
36.44%
Underperform Votes
75
63.56%
Addus HomeCareOutperform Votes
330
68.89%
Underperform Votes
149
31.11%

Hims & Hers Health has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500.

Addus HomeCare has lower revenue, but higher earnings than Hims & Hers Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B4.29-$23.55M$0.5452.80
Addus HomeCare$1.15B1.57$62.52M$4.2423.52

Hims & Hers Health has a net margin of 8.19% compared to Addus HomeCare's net margin of 6.50%. Hims & Hers Health's return on equity of 10.97% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
Addus HomeCare 6.50%9.62%7.37%

Summary

Hims & Hers Health beats Addus HomeCare on 10 of the 19 factors compared between the two stocks.

Remove Ads
Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.81B$3.03B$5.32B$7.56B
Dividend YieldN/A0.34%5.11%4.33%
P/E Ratio22.8229.1221.7717.81
Price / Sales1.571.11378.2693.59
Price / Cash21.6517.2938.1534.64
Price / Book2.293.346.443.99
Net Income$62.52M-$57.02M$3.20B$247.23M
7 Day Performance3.54%-0.10%6.42%7.24%
1 Month Performance10.47%-3.58%-8.66%-6.26%
1 Year Performance3.10%16.13%10.27%-0.18%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.5813 of 5 stars
$99.24
-2.9%
$132.78
+33.8%
+4.4%$1.80B$1.15B22.7133,200Positive News
HIMS
Hims & Hers Health
3.5733 of 5 stars
$27.71
+6.6%
$37.31
+34.7%
+102.1%$6.16B$1.48B62.97650
OPCH
Option Care Health
3.1262 of 5 stars
$32.87
-2.0%
$33.00
+0.4%
+4.7%$5.40B$5.00B27.625,600Short Interest ↑
Positive News
GH
Guardant Health
3.6829 of 5 stars
$41.78
+3.0%
$48.95
+17.2%
+147.3%$5.16B$739.02M-11.741,790
RDNT
RadNet
3.828 of 5 stars
$49.29
+1.2%
$73.25
+48.6%
+10.0%$3.65B$1.83B-704.048,970News Coverage
Positive News
BTSG
BrightSpring Health Services
2.906 of 5 stars
$17.28
+0.8%
$21.67
+25.4%
+70.1%$3.02B$11.27B-66.4635,000News Coverage
Positive News
SHC
Sotera Health
2.4182 of 5 stars
$10.23
-1.1%
$16.00
+56.4%
-5.9%$2.90B$1.10B40.923,000Gap Down
SGRY
Surgery Partners
2.8707 of 5 stars
$20.51
-2.8%
$36.63
+78.6%
-19.0%$2.62B$3.11B-42.7313,500Positive News
PRVA
Privia Health Group
3.8867 of 5 stars
$21.48
-2.2%
$26.67
+24.1%
+29.7%$2.59B$1.74B214.82810Analyst Forecast
High Trading Volume
CON
Concentra Group Holdings Parent
N/A$20.19
-2.1%
$28.50
+41.2%
N/A$2.57B$1.90B13.3711,000Positive News
LFST
LifeStance Health Group
1.9085 of 5 stars
$6.51
-2.0%
$8.50
+30.6%
+13.2%$2.50B$1.25B-25.046,640
Remove Ads

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners